Angle PLC: Parsortix enables analysis in head and neck cancer - Benzinga

Angle PLC: Parsortix enables analysis in head and neck cancer Benzinga The University of Athens work suggest that, for the first time, it might be possible to assess gene expression of head and neck cancers using a Parsortix non-invasive liquid biopsy. Gene expression of biomarkers such as PD-L1 provides key information ...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oPsfSU
via IFTTT